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Available online 24 September 2016Human dental pulp cells (DPCs), which are known to contain a subset of stem cells capable of reforming a dentin
and pulp-like complex upon in vivo transplantation, were isolated from third molars of three healthy donors
and differentiated to a matrix mineralisation phenotype using by culture in dexamethasone and L-ascorbic
acid. qRT-PCR analysis of insulin-like growth factor ( IGF) axis gene expression indicated that all genes, except
insulin-like growth factor 1 (IGF1) and insulin-like growth factor binding protein-1 ( IGFBP-1), were expressed
inDPCs. During differentiation upregulation of insulin-like growth factor binding protein-2 (IGFBP-2) and down-
regulation of insulin-like growth factor binding protein-3 (IGFBP-3) expressionwas observed. Changes in IGFBP-
2 and IGFBP-3mRNA expression were conﬁrmed at the protein level by ELISA of DPC conditionedmedium func-
tional analysis indicated that IGF1 stimulated the differentiation of DPCs and that the activity of the growth factor
was enhanced by pre-complexation with IGFBP-2 but inhibited by pre-complexation with IGFBP-3. Therefore
changes in IGFBP-2 and -3 expression during differentiation form part of a co-ordinated functional response to
enhance the pro-differentiative action of IGF1 and represent a novel mechanism for the regulation of DPC
differentiation.logy, Faculty
y), J.Beattie@
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IGF axis1. Introduction
The increasing demand for alternatives to bone grafting as a method
of treating critical bonedefects has led to a growing interest in cell based
regenerative therapies and selection of appropriate cell sources for bone
tissue engineering is a key research area. Recently, cells derived from
human dental pulp (DPCs) have been characterised as an accessible
source of multipotent stem cells which can be differentiated to a matrix
mineralised phenotype. In vivo transplant studies with DPCs indicate a
tissue formation whose phenotype most resembles dentin in structure
although the processes of dentinogenesis and osteogenesis share regu-
latorymechanisms and gene expression proﬁles (Gronthos et al., 2002).
Subsequently stem cells have been isolated from other tissue niches
within the oral cavity including periodontal ligament (PDLSCs) (Seo et
al., 2004), apical papilla (SCAP) (Sonoyama et al., 2006), dental follicleof Dentistry, Suez
leeds.ac.uk
pen access article under(DFSCs) (Morsczeck et al., 2005), and exfoliated deciduous teeth
(SHED) (Gronthos et al., 2000a). As dental tissues develop from oral ec-
toderm and neural crest derivedmesenchyme, they contain pluripotent
stem cell populations which display a developmental potential similar
to embryonic stem cells (ESCs) and are able to differentiate into several
different lineages (Le Douarin & Dupin, 2003; Le Douarin et al., 2004).
Typically undifferentiated cells display a ﬁbroblast-like morphology
with associated high efﬁciency for adherent colony formation and
high proliferative potential (Kerkis & Caplan, 2011). All of these factors
suggest that adult dental tissuesmay provide a source ofmaterial (often
discarded in the clinic) to provide multipotent cells for subsequent tis-
sue engineering studies.
Also critical to the success of hard tissue engineering strategies is the
selection and use of an appropriate growth factor regimen. Although
several growth factors are reported to play an important role in the pro-
cess of matrix mineralisation, IGF-1 is themost abundant growth factor
in bonematrix (Canalis et al., 1993) and several studies have shown that
the IGF axis plays an important role in the development and mainte-
nance of skeletal tissues (Delany et al., 2001; Gan et al., n.d.; Wong et
al., 1990; Yang et al., n.d.; Zhang et al., 2002). IGF1 also regulates the
osteogenic differentiation of mesenchymal stem cells (MSCs) viathe CC BY license (http://creativecommons.org/licenses/by/4.0/).
518 H. Alkharobi et al. / Stem Cell Research 17 (2016) 517–522mTOR signalling (Xian et al., 2012), BMP9 (Chen et al., n.d.) and MEK-
ERK mediated upregulation of the transcriptional co-activator with
PDZ-binding motif (TAZ) protein (Xue et al., 2013). These alterations
in cell physiology ultimately lead to expression of characteristic osteo-
blast marker genes, the phenotypic differentiation of osteoblasts and
the process of bone accretion (Koch et al., 2005).While some of themo-
lecular details associated with IGF action on osteogenic differentiation
are becoming apparent much less information is available regarding
the potential functions of the six high afﬁnity IGF binding proteins
(IGFBP 1–6) in this process. Such studies are largely limited to the role
of IGFBP-4 and IGFBP-5 in mature osteoblasts or bone tissue (Andress,
1995; Andress & Birnbaum, 1992; Durham et al., 1995; Durham et al.,
1994) with little information on the role of IGFBPs on the process of dif-
ferentiation per se.
To further investigate the role of IGFBPs in differentiation we
have used DPCs to examine the expression of the IGF axis during
the process of matrix mineralisation in these cells. We show that,
with the exception of IGF-1 and IGFBP-1, all components of the IGF
axis are expressed at moderate to high levels in both basal and
mineralising conditions in these cells. We describe consistent and re-
producible changes in expression of IGFBP-2 and -3 in cell cultures
derived from all donors during differentiation to a mineralising phe-
notype at both mRNA and protein levels. In addition we demonstrate
that IGFBP-2 and IGFBP-3 perform co-ordinated roles as an enhancer
or inhibitor respectively of the pro- differentiating activity of IGF1.
As IGFBP-2 and -3 have previously been unreported as regulators of
matrix mineralisation we believe our data provide a basis for novel
further investigations on the role of these two genes in this process
and may impact on the design of future hard tissue engineering
strategies.0.00001
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Fig. 1. Expression of the IGF axis inDPCs (donor1): expression of IGF-1, IGF-2, IGF-1R, IGF-2R and
relative to GAPDH are shown. Data are presented as 2−ΔCt and represent the mean ± SD of tri2. Materials & methods
2.1. Materials
Tissue culture medium α-MEM, FBS and phosphate buffered
saline (PBS) were from Lonza (Slough, UK); penicillin/streptomycin
(PS), L-glutamine, L-ascorbic acid and dexamethasone, were from
Sigma (Dorset, UK). Collagenase (Type I), was from Life Technologies
(UK). Tissue culture plastic was from Corning (Amsterdam, Nether-
lands). Recombinant hIGF1, hIGFBP-2 and hIGFBP-3 were supplied by
R&D Systems (Abingdon, UK). All other reagents were of analytical
grade or better.2.2. Methods
2.2.1. Tissue culture
Freshly extracted healthy third molars were collected from patients
(20–35 years of age) at the dental clinic of Leeds Dental Institute after
obtaining informed written consent. Ethical approval and teeth were
supplied through the Leeds Dental Institute Tissue Bank (LDI Research
Tissue Bank; Ref No. 130111/AH/75). DPCs were isolated from third
molars using collagenase enzyme digestion as described previously
(Gronthos et al., 2000b; El-Gendy et al., 2012). DPCs at passage 4 were
cultured in basal media (α-MEM, supplemented with 20% FBS, 1% pen-
icillin streptomycin (P/S)), and 1% L-glutamine or cultured under
mineralisation inducing conditions – (basal media+ 10 nM dexameth-
asone and 50 μg/ml of L-ascorbic acid). Cultures were routinely termi-
nated at 1 and 3 wk. time points for qRT-RCR analysis of gene
expression, ELISA and histological staining (ALP and Alizarin Red).0.00001
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IGFBP1–6 after 1wkand 3wk incubation under basal (B) andmineralising (O) conditions
plicate technical replicates from duplicate experiments.
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RNeasy®Mini Kit (Qiagen, UK)wasused to extract andpurifymRNA
exactly according to the manufacturer's protocol. mRNA quality was
conﬁrmed by monitoring A260/280 ratios and 1 μg mRNA was used
for ﬁrst strand cDNA synthesis using High Capacity RNA to cDNA kit
(Applied Biosystems, UK) was used according to the manufacturer's
protocol. qRT-PCR reactions were conducted in a total volume of 20 μl
using TaqMan probes and primers. Expression of each gene was
analysed in triplicate in 96 well qRT-PCR plates. Each plate contained a
non-template and a reverse transcriptase negative control. qRT-PCR re-
actionswere ampliﬁed using the Roche 480 Light Cycler®. Gene expres-
sion analysis was carried out using the ΔCt method. Ct values of all
genes of interest were normalised to the house keeping gene GAPDH.
Gene expression undermatrix mineralisation conditionswas compared
to controls cultured under basal conditions using the ΔΔCt method
which is plotted as ordinate and indicates fold differences in expression0.01
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Fig. 2. Changes in IGFBP-2 and -3 expression following the differentiation of DPCs at 1 (left p
mineralising v basal culture conditions and are expressed as 2−ΔΔCt representing mean ± SD
and donor 3 (bottom panel).mineralising v basal (El-Gendy et al., 2012). Assay identiﬁers for
TaqMan qRT-PCR reactions are presented in Supplementary Table II.
2.2.3. Elisa
IGFBP-2 and IGFBP-3 concentrations in conditioned media were de-
termined by enzyme-linked immunosorbent assay (ELISA) (R & D Sys-
tems, UK) exactly according to the manufacturer's protocol. 1 ml of
conditionedmediumwas collected frombasal andmineralising cultures
at both 1 (0–7 day conditioning period) and 3wk (14–21day condition-
ing period) time points, centrifuged brieﬂy to remove cell debris
and stored at −80 °C prior to assay. Standard curves for ELISA were
linear between 0.0625 and 4 ng/ml (IGFBP-2) and 0.781–50 ng/ml
(IGFBP-3). Samples of conditioned medium were appropriately diluted
to fall in this region of the standard curve. Data is presented for each in-
dividual donor and combined data is presented as a global analysis in
Supplementary Figs. 2 and 3.P-2
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anels) and 3 (right panels) wk time points. Data show fold changes in gene expression
of technical triplicates for cells derived from donor 1 (top panel), donor 2 (middle panel)
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ALP activity was assayed as described previously (Kim et al., 2013;
Kim et al., 2011) with some modiﬁcations. Brieﬂy DPCs were grown to
conﬂuence and incubated with IGF1± IGFBP-2/3 in mineralisingmedi-
um.Mediumwas changed at days 4, 7, 10 and cultureswere terminated
at day 14. Cells were lysed by the addition of 200 μl 0.1% Triton X-100
followed by three cycles of freeze-thawing. Lysates were centrifuged
(5 min; 10,000g) and 20 μl was assayed for ALP activity. Data are pre-
sented as nmol p-nitrophenol (pNP) formed per μg DNA.
2.3. Statistics
Data were analysed for signiﬁcance using Student's unpaired t-test
(Graph Pad 6.0). Signiﬁcance was reported at p b 0.05.
3. Results
Three donors were used to isolate dental pulp from healthy third
molars. Donor proﬁle is shown in Supplementary Table I. Dental pulp
cells were treated with mineralisation medium for 1 and 3 wk. In0
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Fig. 3. IGFBP-2 (left panels) and IGFBP-3 (right panels) concentrations in basal (grey bars) and d
donor 2 (middle panels) and donor 3 (bottompanels). Data is expressed as ng/ml and represent
cultures for each donor at 1 and 3 wk time points. Data was analysed by Student's unpaired t-order to conﬁrm differentiation we examined the expression of alkaline
phosphatase (ALPL), runt related transcription factor 2 (Runx2) and
osteocalcin (OCN) under both basal andmineralising culture conditions.
ALPL is an early marker of differentiation and was upregulated approx-
imately 3-fold at 1wkwith expression levels returning to basal levels at
3 wk (p b 0.05 1 wk v 3 wk). Runx2 is a key transcription factor regulat-
ing matrix mineralisation and was upregulated at both time points al-
though there was a tendency toward higher levels of expression at
3 wk (3-fold) compared to 1 wk (1.5-fold). OCN is a later marker of dif-
ferentiation and is upregulated approximately 2-fold at 3 wk compared
to 1wk (p b 0.01 1wk v 3wk) Supplementary Fig. 1A. In addition differ-
entiated DPCs showed positive staining for both alkaline phosphatase
(Supplementary Fig. 1B) and Alizarin Red (Supplementary Fig. 1C) at
both 1 and 3 wk time points. This data conﬁrms the differentiation of
DPCs toward a mineralising phenotype under our experimental
conditions.
We next analysed expression of IGF axis genes (IGF-1, IGF-2, IGF-1R,
IGF-2R and IGFBP1–6) in DPCs under basal andmineralising conditions.
All 10 genes were expressed under both basal and mineralising condi-
tions although in our cultures IGF-1 and IGFBP-1 were expressed atedium
lising medium
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test *p b 0.05 **p b 0.05 ***p b 0.001 ****p b 0.0005.
521H. Alkharobi et al. / Stem Cell Research 17 (2016) 517–522low levels Ct N 30. For IGFBPs the level of expression was IGFBP-4 N
IGFBP-5 N IGFBP-6 N IGFBP-2 N IGFBP-3 N IGFBP-1 – (Fig. 1). IGFBP-4,
-5 and -6 expression did not alter during differentiation of DPCs. In con-
trast, in each analysis of pulp cells obtained from all 3 donors we found
that IGFBP-2 and IGFBP-3 expressionwere reciprocally regulated during
differentiation at both 1 wk and 3 wk time points (Fig. 2). Induction of
IGFBP-2 varied from around 4–20 fold following differentiation and
similar fold reductions in IGFBP-3 expression were also seen. We also
measured IGFBP-2 and -3 concentrations using ELISA (see Section 2.2)
of conditioned medium (CM) from cells cultured under basal or
mineralising conditions (Fig. 3). In agreement with our qRT-PCR data,
IGFBP-2 protein levels in CM were elevated following differentiation
of cells derived from all donors at both 1 and 3 wk time points.
In most instances these differences achieved statistical signiﬁcance
(Fig. 3). Similarly, the decrease in IGFBP-3 mRNA expression following
differentiation shown in our qRT-PCR experiments was reﬂected in re-
duced IGFBP-3 protein concentrations in conditioned cell media. For
cultures derived from all donors signiﬁcant decreases in IGFBP-3 con-
centrations were seen following differentiation of cells at both 1 and
3 wk time points Global analysis of IGFBP-2 and IGFBP-3 protein con-
centrations is presented in Supplementary Figs. 2 and 3.
To examine the functional role of IGFBP-2 and -3 we conducted the
experiments described in Fig. 4 where the effects of IGFBP-2 and -3
were examined either uncomplexed or complexed with IGF1. The data
indicated that IGF1 stimulated ALP activity in DPCs in a dose dependant
manner and although there were no statistically signiﬁcant effects of
IGFBPs on their own, at equimolar concentrations of IGF: IGFBP, IGF1 ac-
tivity is enhanced by IGFBP-2 and inhibited by IGFBP-3. Such effects are
consistent with a functional role for both IGFBPs and are consistent
with the changes in IGFBP mRNA and protein concentrations seen
during the differentiation of DPCs. At higher concentrations of
IGF1 maximum stimulation of ALP occurs and at this higher IGF: IGFBP
molar ratio (10) the inhibitory effect of IGFBP-3 is overcome. Interest-
ingly DPCs appeared less sensitive to stimulation by IGF2 (Supplemen-
tary Fig. 4).1 10 100
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Fig. 4. The effect of IGFBP-2 and IGFBP-3 on the mineralisation activity of exogenous IGF1.
DSCs from donor 2 were incubated in mineralisation medium containing IGFs (0–100
nM) ± IGFBPs at a ﬁxed concentration of 10 nM. Incubations were conducted for
14 days before assay of ALP activity. Data are presented as mean ± SD nmol pNP/μg
DNA and represent triplicate measurement of ALP activity in two separate wells for each
IGF1 concentration. In some instances symbol sizes are larger than SDs. Data was
analysed by unpaired t-test *p b 0.01 v IGF1 alone.4. Discussion
We have demonstrated reciprocal changes in IGFBP-2 and IGFBP-3
mRNA and protein expression in dental pulp stromal cells during differ-
entiation to a mineralising phenotype and show that these changes are
co-ordinated with the functions of both IGFBPs to enhance (IGFBP-2) or
inhibit (IGFBP-3) the mineralising activity of IGF1 in these cells. Al-
though IGF1 has been reported previously to promote the differentia-
tion of human dental pulp stem cells via mTor (Feng et al., 2014) and
MAPK/Stat-3 (Vandomme et al., 2014) signalling pathways there is
only a limited literature describing IGFBP-2 and/or IGFBP-3 expression
and activity during osteogenic differentiation. A direct effect of IGFBP-
2 on the osteoblastic differentiation of rat calvarial cells via a receptor
tyrosine phosphatase β (RPTPβ) basedmechanismwas recently report-
ed (Xi et al., 2014). Whether such a mechanism is associated with the
potentiation of IGF1 activity by IGBP-2 reported in the current study is
unknown. A potentiating effect of IGFBP-2 on IGF-2 stimulation of alka-
line phophatase activity in differentiating rat tibial osteoblast cultures
(Palermo et al., 2004) was reported although we found that DPCs
were less sensitive to IGF2 stimulation compared to IGF1 in terms of
stimulation of ALP activity (Supplementary Fig. 4). This suggests that
the pro-mineralising action of IGFs is principally signalled through the
IGF1R although conﬁrmation of this should be sought through the use
of speciﬁc IGF1R inhibitors. There are two reports which demonstrate
upregulation of IGFBP-5 expression during mineralisation of dental
pulp cells. Microarray analysis indicated an 8-fold increase in IGFBP-5
expression in DPCs derived from non-carious wisdom teeth following
10 days treatment with mineralisation medium although this group
did not conﬁrm IGFBP-5 protein expression (Mori et al., 2011; Mori et
al., 2010). Although we found that IGFBP-5 was expressed under both
basal and mineralising conditions in DPCs we did not ﬁnd any changes
in gene expression under our experimental conditions in any of our do-
nors. Although it is difﬁcult to reconcile these results factors such as dif-
ferences in precise tissue culture conditions or donor proﬁles may be
involved.
The IGF axismay also play an indirect role(s) in the differentiation of
dental tissues. For example IGF-1 increased extra-cellular matrix secre-
tion by dental-pulp derived ﬁbroblasts (Nakashima, 1992) via the in-
duction of bone morphogenetic protein (BMP)-2 expression (Li et al.,
1998). Although our qRT-PCR data indicated a low abundance of IGF-1
mRNA expression in DPCs, in vivo dental pulp tissue is well vascularised
and would therefore have access to systemic IGF1 and our data would
suggest that growth factor activity could be modulated by locally
expressed IGFBP-2 and -3. Conversley IGF-2 and IGF-1Rwere expressed
at moderate to high levels in our experiments conﬁrming previous re-
ports (Caviedes-Bucheli et al., 2004; Shi et al., 2001). Both IGF-1 and
IGF-2 (acting via the IGF-1R) can induce ALP activity in canine dental
pulp cells (Onishi et al., 1999) and IGF-2 secretion was reported during
matrix mineralisation of human dental pulp derived ﬁbroblasts
(Reichenmiller et al., 2004). IGF axis components are present in other
dental structures with IGF-1 and -2 along with all six IGFBPs present
in the ECM of the periodontal ligament and IGF-1R present on the sur-
face of periodontal ligament derived ﬁbroblasts (Gotz et al., 2006). A
very recent study using stem cell populations isolated from apical
papillae (SCAP) reported the stimulation of cell proliferation, ALP
expression and mineralisation activity by IGF-1. Simultaneously, ex-
pression of odontogenic markers (dentin sialoprotein and dentin
sialophosphoprotein)was downregulated arguing for a bias in IGF-1 ac-
tion toward bone formation and away from odontogenic differentiation
in this tissue niche (Wang et al., n.d.). However it should be noted that
microscopic conﬁrmation of appropriate bone tissue structure was not
rigorously established in these studies and this area requires further in-
vestigation. In a detailed study of IGF axis expression in differentiating
ameloblasts, position speciﬁc expression of IGF-1, IGF-2, IGF-1R and
IGF-2R toward the outer enamel layer and away from pulp facing ame-
loblasts was reported arguing for the importance of the IGF axis in
522 H. Alkharobi et al. / Stem Cell Research 17 (2016) 517–522development of this tissue (Caviedes-Bucheli et al., 2009; Yamamoto et
al., 2006) and an elegant study demonstrating the developmental stage-
dependent expression of IGF-1 in the continually erupting rat incisor
model (Joseph et al., 1996) also argues strongly for a role of the IGF
axis in the development of dental tissues.
In our current study IGFBP-2 levels were approximately 10-fold
higher than those of IGFBP-3 suggesting that the large induction of
IGFBP-2 may play a more import role in the differentiation of DPCs
than the decrease seen in IGFBP-3 concentrations. Although an exten-
sive literature describes both IGF-dependent and IGF independent ef-
fects of IGFBPs – reviewed in Annunziata et al. (2011) - in most
instances quantitative aspects related to IGF and IGFBP concentrations
in the local tissue environment have largely been ignored. Our data sug-
gest that the ratio of IGF:IGFBP present in an experimentalmodel can be
important in determining the overall biological response (Fig. 4). These
factors are also important with respect to the functional redundancy
displayed by IGFBPs in some tissue culture and whole animal studies
(Murphy, 1998; Pintar et al., 1995) and the accurate quantiﬁcation of
local IGF axis proteins in vivo or in vitro is essential for an understanding
of biological outcomes. Notwithstanding these arguments evidence
suggests an important role for the IGF axis in the differentiation and de-
velopment of various dental structures. However there are several gaps
in our knowledge of the role of various members of this molecular axis
(particularly IGFBPs) in this process and it is hoped that future studies
will shed some light in this area and also assist in design of strategies
aimed at hard tissue engineering using multipotent stem cells derived
from dental pulp and other stem cell niches within the oral cavity.Acknowledgements
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